[PRESS RELEASE] – SMITH FALLS, Ontario, May 29, 2026 – Canopy Growth Corp. announced the relaunch of the Tweed brand in the German medical market, alongside the introduction of three cannabis strains developed by MTL Cannabis Corp. (MTL), a wholly-owned subsidiary of the company. The dual milestone represents the company’s first international product release following its recent acquisition of MTL.
The Tweed brand relaunch – now powered by MTL’s premium genetics – signals the company’s commitment to leveraging the full equity of its legacy brand in key international markets and comes as Germany’s medical cannabis market continues to expand rapidly, approaching $1 billion in annual value in 2025. The MTL acquisition has enhanced Canopy Growth’s capacity to meet rising demand in key international markets, including Germany, while reintroducing a brand that physicians and patients have come to trust.
“Germany is one of the fastest-growing medical cannabis markets globally, and demand continues to scale rapidly,” Canopy Growth CEO Luc Mongeau said. “The relaunch of our Tweed brand is a meaningful moment for us, reflecting both the strength of what we have built, and our commitment to delivering consistent, high-quality cannabis that physicians can prescribe with confidence and patients can rely on as part of their care. We believe the European Union represents a tremendous opportunity for Canopy, and Germany is just the beginning.”
The initial launch includes three cultivars – Pablo’s Revenge, Dante’z Inferno and Frost’d Flakes – selected for their quality and consistency. Up to five MTL-derived strains are expected to be introduced in June 2026, with further portfolio expansion planned throughout the year.
The company also announced that it has been granted a management cease trade order effective as of May 28, 2026, by its principal regulator, the Ontario Securities Commission under National Policy 12-203 – Management Cease Trade Orders. This follows the company’s announcement on May 15, 2026, regarding certain non-cash technical errors in the company’s accounting relating to certain share-settled warrants of the company with exercise prices denominated in U.S. dollars, first issued during the fiscal year ended March 31, 2024.
The company intends to refile the relevant financial statements (the “refiling”) in its annual report on Form 10-K for the fiscal year ended March 31, 2026, which is expected to be filed with Canadian securities regulators and with the United States Securities and Exchange Commission (SEC) on June 15, 2026 (the “comprehensive Form 10-K”).
